Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Low-level laser therapy for the prevention of low salivary flow rate after radiotherapy and chemotherapy in patients with head and neck cancer

Low-level laser therapy, administered concomitantly with radiotherapy and chemotherapy, appears to mitigate treatment-induced salivary hypofunction in patients with head and neck cancer.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied 23 head and neck cancer patients, 13 of whom received low-level laser therapy during radiotherapy and chemotherapy and 10 who received clinical care only. Salivary flow was measured before treatment and 30 days after it ended. The authors report that laser-treated patients had higher salivary flow rates than the comparison group, which they describe as an apparent mitigation of treatment-induced salivary hypofunction.

Participants
23
Who or what was studied
Patients with head and neck cancer receiving radiotherapy and chemotherapy
Wavelengths
660, 780 nm
Limits stated in the abstract
The sample was small (23 patients) and the abstract does not describe randomization, which limits confidence in the comparison.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Objective

To determine whether low-level laser therapy can prevent salivary hypofunction after radiotherapy and chemotherapy in head and neck cancer patients.

Materials And Methods

We evaluated 23 head and neck cancer patients, of whom 13 received laser therapy and 10 received clinical care only. An InGaAlP laser was used intra-orally (at 660 nm and 40 mW) at a mean dose of 10.0 J/cm(2) and extra-orally (at 780 nm and 15 mW) at a mean dose of 3.7 J/cm(2), three times per week, on alternate days. Stimulated and unstimulated sialometry tests were performed before the first radiotherapy and chemotherapy sessions (N0) and at 30 days after the end of treatment (N30).

Results

At N30, the mean salivary flow rates were significantly higher among the laser therapy patients than among the patients who received clinical care only, in the stimulated and unstimulated sialometry tests (p = 0.0131 and p = 0.0143, respectively).

Conclusion

Low-level laser therapy, administered concomitantly with radiotherapy and chemotherapy, appears to mitigate treatment-induced salivary hypofunction in patients with head and neck cancer.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
660 nm, 780 nm
Power
40 mW, 15 mW

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser, Low-level laser therapy, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies